253 related articles for article (PubMed ID: 28461145)
1. Paclitaxel-coated versus uncoated balloon angioplasty for femoropopliteal artery in-stent restenosis.
Wu R; Li Z; Wang M; Chang G; Yao C; Wang S
Int J Surg; 2017 Jun; 42():72-82. PubMed ID: 28461145
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for the treatment of in-stent restenosis of the femoropopliteal arteries.
Kayssi A; Al-Jundi W; Papia G; Kucey DS; Forbes T; Rajan DK; Neville R; Dueck AD
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD012510. PubMed ID: 30684445
[TBL] [Abstract][Full Text] [Related]
3. Drug-Coated Balloon Versus Standard Balloon for Superficial Femoral Artery In-Stent Restenosis: The Randomized Femoral Artery In-Stent Restenosis (FAIR) Trial.
Krankenberg H; Tübler T; Ingwersen M; Schlüter M; Scheinert D; Blessing E; Sixt S; Kieback A; Beschorner U; Zeller T
Circulation; 2015 Dec; 132(23):2230-6. PubMed ID: 26446728
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial.
Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F
JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials.
Cassese S; Byrne RA; Ott I; Ndrepepa G; Nerad M; Kastrati A; Fusaro M
Circ Cardiovasc Interv; 2012 Aug; 5(4):582-9. PubMed ID: 22851526
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
Grotti S; Liistro F; Angioli P; Ducci K; Falsini G; Porto I; Ricci L; Ventoruzzo G; Turini F; Bellandi G; Bolognese L
J Endovasc Ther; 2016 Feb; 23(1):52-7. PubMed ID: 26511896
[TBL] [Abstract][Full Text] [Related]
7. Network meta-analysis of drug-coated balloon angioplasty versus primary nitinol stenting for femoropopliteal atherosclerotic disease.
Abdoli S; Mert M; Lee WM; Ochoa CJ; Katz SG
J Vasc Surg; 2021 May; 73(5):1802-1810.e4. PubMed ID: 33249205
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Paclitaxel-Coated Versus Uncoated Percutaneous Transluminal Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease: One-Year Results of the ILLUMENATE European Randomized Clinical Trial (Randomized Trial of a Novel Paclitaxel-Coated Percutaneous Angioplasty Balloon).
Schroeder H; Werner M; Meyer DR; Reimer P; Krüger K; Jaff MR; Brodmann M;
Circulation; 2017 Jun; 135(23):2227-2236. PubMed ID: 28424223
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
10. Drug-coated balloon angioplasty for in-stent restenosis of femoropopliteal arteries: a meta-analysis.
Cassese S; Ndrepepa G; Kufner S; Byrne RA; Giacoppo D; Ott I; Laugwitz KL; Schunkert H; Kastrati A; Fusaro M
EuroIntervention; 2017 Jul; 13(4):483-489. PubMed ID: 28169215
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison.
Fusaro M; Cassese S; Ndrepepa G; King LA; Tada T; Ott I; Kastrati A
Int J Cardiol; 2013 Oct; 168(4):4002-9. PubMed ID: 23890909
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-Analysis of Drug-Coated Balloon Angioplasty for In-Stent Restenosis in Femoropopliteal Artery Disease.
Zhen Y; Ren H; Chen J; Chang Z; Wang C; Zheng J
J Vasc Interv Radiol; 2022 Apr; 33(4):368-374.e6. PubMed ID: 34915164
[TBL] [Abstract][Full Text] [Related]
13. Treatment of femoropopliteal in-stent restenosis with paclitaxel-eluting stents.
Zeller T; Dake MD; Tepe G; Brechtel K; Noory E; Beschorner U; Kultgen PL; Rastan A
JACC Cardiovasc Interv; 2013 Mar; 6(3):274-81. PubMed ID: 23517839
[TBL] [Abstract][Full Text] [Related]
14. Femoropopliteal In-stent Restenosis Repair: Midterm Outcomes After Paclitaxel Eluting Balloon Use (PLAISIR Trial).
Bague N; Julia P; Sauguet A; Pernès JM; Chatelard P; Garbé JF; Penillon S; Cardon JM; Commeau P; Planché O; Guyomarch B; Gouëffic Y
Eur J Vasc Endovasc Surg; 2017 Jan; 53(1):106-113. PubMed ID: 27890526
[TBL] [Abstract][Full Text] [Related]
15. Drug-coated balloon angioplasty versus balloon angioplasty for treating patients with in-stent restenosis in the femoropopliteal artery: A meta-analysis.
Cao S; He T; Xie J; Feng H; Liu K; Qu B; Wu X
Medicine (Baltimore); 2021 Apr; 100(16):e25599. PubMed ID: 33879723
[TBL] [Abstract][Full Text] [Related]
16. Comparison between paclitaxel-coated balloon and standard uncoated balloon in the treatment of femoropopliteal long lesions in diabetics.
Du X; Wang F; Wu DM; Zhang MH; Jia X; Zhang JW; Zhuang BX; Zhao Y; Guo PF; Bi W; Fu WG; Guo W; Wang SM
Medicine (Baltimore); 2019 Mar; 98(13):e14840. PubMed ID: 30921183
[TBL] [Abstract][Full Text] [Related]
17. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and femoropopliteal in-stent restenosis.
Voll F; Wolf F; Ingwersen M; Kinstner CM; Kufner S; Ibrahim T; Ott I; Krankenberg H; Fusaro M; Cassese S
Vasa; 2022 Jul; 51(4):247-255. PubMed ID: 35543439
[No Abstract] [Full Text] [Related]
19. Meta-Analysis-Derived Benchmarks of Patency and Target Lesion Revascularization of Percutaneous Balloon Angioplasty from Prospective Clinical Trials of Symptomatic Femoropopliteal In-Stent Restenosis.
Shammas NW; Jones-Miller S; Lemke J
J Vasc Interv Radiol; 2016 Aug; 27(8):1195-203. PubMed ID: 27350033
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis.
Anantha-Narayanan M; Love K; Nagpal S; Sheikh AB; Regan CJ; Mena-Hurtado C
Expert Rev Med Devices; 2020 Jun; 17(6):533-539. PubMed ID: 32525406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
